Nicholas P. Silverman

Vanda Pharmaceuticals Inc. v. FDA: Industry's Latest Attempt To Clarify Off-Label Promotion Rules

United States v. Regeneron: Where "But-For" Art Thou, Romeo?

DOJ Issues Long-Anticipated Proposed Rulemaking To Modernize FARA Regulations

DOJ's Long-Awaited Update To The FARA Regulations: What You Need To Know

Fifth Circuit's Ruling In United States v. Rafoi